Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $1.194B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 10.9%
Value $130M Shares 1,544,163 Est. Cost $80.19 Unrealized +7.5%
STAA STAAR SURGICAL CO 8.9%
Value $106M Shares 3,278,523 Est. Cost $13.06 Unrealized +158.0%
INSM INSMED INC 8.1%
Value $97.07M Shares 6,055,623 Est. Cost $17.16 Unrealized +38.1%
EPIZYME INC 7.2%
Value $86.11M Shares 5,551,803 Est. Cost $15.12 Unrealized
UTHR UNITED THERAPEUTICS CORP 7.0%
Value $83.12M Shares 876,575 Est. Cost $88.73 Unrealized +7.1%
KARYOPHARM THERAPEUTICS INC 6.9%
Value $82.6M Shares 4,299,901 Est. Cost $17.42 Unrealized
ABIOMED INC 6.1%
Value $72.98M Shares 502,745 Est. Cost $37.80 Unrealized
IMMUNOMEDICS INC 6.0%
Value $71.32M Shares 5,290,746 Est. Cost $13.38 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 5.8%
Value $68.93M Shares 1,631,524 Est. Cost $27.34 Unrealized +50.7%
FOLD AMICUS THERAPEUTICS INC 5.8%
Value $68.82M Shares 7,447,618 Est. Cost $7.59 Unrealized +25.2%
ALEXION PHARMACEUTICALS INC 4.8%
Value $57.69M Shares 642,491 Est. Cost $121.54 Unrealized
AIMMUNE THERAPEUTICS INC 4.0%
Value $47.52M Shares 3,295,712 Est. Cost $22.84 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.6%
Value $42.84M Shares 4,134,846 Est. Cost $11.21 Unrealized +10.6%
MOMENTA PHARMACEUTICALS INC 3.5%
Value $41.56M Shares 1,527,956 Est. Cost $14.06 Unrealized
CLOVIS ONCOLOGY INC 2.5%
Value $29.48M Shares 4,635,789 Est. Cost $48.59 Unrealized
AMAG PHARMACEUTICALS INC 1.6%
Value $18.56M Shares 3,002,748 Est. Cost $29.07 Unrealized
SAGE THERAPEUTICS INC 1.4%
Value $16.85M Shares 586,674 Est. Cost $48.62 Unrealized
ALGN ALIGN TECHNOLOGY INC 1.1%
Value $13.26M Shares 76,205 Est. Cost $114.31 Unrealized +109.5%
PBYI PUMA BIOTECHNOLOGY INC 1.0%
Value $11.78M Shares 1,396,163 Est. Cost $28.26 Unrealized -65.6%
REVANCE THERAPEUTICS INC 0.8%
Value $9.112M Shares 615,705 Est. Cost $15.01 Unrealized
PRTA PROTHENA CORP PLC 0.7%
Value $8.296M Shares 775,296 Est. Cost $32.98 Unrealized -63.3%
WRIGHT MEDICAL GROUP NV 0.6%
Value $6.96M Shares 242,940 Est. Cost $23.42 Unrealized
DICERNA PHARMACEUTICALS INC 0.5%
Value $6.095M Shares 331,813 Est. Cost $5.39 Unrealized
RIGEL PHARMACEUTICALS INC 0.5%
Value $5.526M Shares 3,542,551 Est. Cost $3.40 Unrealized
KLDO KALEIDO BIOSCIENCES INC 0.4%
Value $4.846M Shares 787,999 Est. Cost $13.76 Unrealized -52.6%
CYTK CYTOKINETICS INC 0.1%
Value $1.458M Shares 123,686 Est. Cost $6.71 Unrealized +90.0%
ALIMERA SCIENCES INC 0.1%
Value $804K Shares 200,919 Est. Cost $4.88 Unrealized
ZOGENIX INC 0.1%
Value $730K Shares 29,500 Est. Cost $13.36 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.1%
Value $725K Shares 66,100 Est. Cost $9.38 Unrealized 0.0%
RETROPHIN INC 0.1%
Value $686K Shares 47,000 Est. Cost $14.60 Unrealized
INTRA-CELLULAR THERAPIES INC 0.0%
Value $575K Shares 37,400 Est. Cost $34.30 Unrealized
SUNESIS PHARMACEUTICALS INC 0.0%
Value $482K Shares 1,162,473 Est. Cost $4.37 Unrealized
URGN UROGEN PHARMA LTD 0.0%
Value $437K Shares 24,500 Est. Cost $27.01 Unrealized 0.0%
MARINUS PHARMACEUTICALS INC 0.0%
Value $254K Shares 125,321 Est. Cost $4.17 Unrealized
MINERVA NEUROSCIENCES INC 0.0%
Value $219K Shares 36,319 Est. Cost $5.62 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $182K Shares 73,500 Est. Cost $7.53 Unrealized -40.2%
IDERA PHARMACEUTICALS INC 0.0%
Value $102K Shares 77,044 Est. Cost $8.90 Unrealized